You can buy or sell Heat Biologics and other stocks, options, ETFs, and crypto commission-free!
Heat Biologics, Inc. Common Stock, also called Heat Biologics, is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. Read More The firm's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the firm's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Durham, NC.
Durham, North Carolina
52 Week High
52 Week Low
Stock Price, News, & Analysis for Heat Biologics
Heat Biologics, Inc., a biopharmaceutical company, focuses on developing approaches to activate and co-stimulate a patient's immune system against cancer in the United States. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors hot and be administered in combination with checkpoint inhibitors and other immuno-modulators to enhance clinical effectiveness. Its TCAP product candidates include ImPACT platform technology that develops product candidates...
Simply Wall StFeb 23
Is Heat Biologics, Inc. (NASDAQ:HTBX) Excessively Paying Its CEO?
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! In 2008 Jeff Wolf was appointed CEO of Heat Biologics, Inc. (NASDAQ:HTBX). This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. Then we’ll look at a snap shot of the business growth. And finally – as a second measure of performance – we will look at the returns shareholders have received over the last few years. This method ...
-$0.20 per share
Expected Today, After Hours